ACET
Income statement / Annual
Last year (2024), Adicet Bio, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Adicet Bio, Inc.'s net income was -$117.12 M.
See Adicet Bio, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
06/30/2017 |
06/30/2016 |
06/30/2015 |
| Operating Revenue |
$0.00 |
$0.00 |
$24.99 M |
$9.73 M |
$17.90 M |
$995,000.00 |
$8.18 M |
$558.52 M |
$546.95 M |
$510.18 M |
| Cost of Revenue |
$0.00
|
$6.10 M
|
$5.01 M
|
$0.00
|
$0.00
|
$125,000.00
|
$80,000.00
|
$5,000.00
|
$411.52 M
|
$395.48 M
|
| Gross Profit |
$0.00
|
-$6.10 M
|
$19.98 M
|
$9.73 M
|
$17.90 M
|
$870,000.00
|
$8.10 M
|
$558.52 M
|
$135.43 M
|
$114.70 M
|
| Gross Profit Ratio |
0
|
0
|
0.8
|
1
|
1
|
0.87
|
0.99
|
1
|
0.25
|
0.22
|
| Research and Development Expenses |
$99.32 M
|
$106.04 M
|
$71.25 M
|
$48.94 M
|
$34.33 M
|
$23.69 M
|
$14.72 M
|
$16.84 M
|
$5.94 M
|
$5.22 M
|
| General & Administrative Expenses |
$28.29 M
|
$26.53 M
|
$26.30 M
|
$22.22 M
|
$22.76 M
|
$8.69 M
|
$8.43 M
|
$76.82 M
|
$73.16 M
|
$65.21 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$74.78 M
|
-$73.16 M
|
$0.00
|
| Selling, General & Administrative Expenses |
$28.29 M
|
$26.53 M
|
$26.30 M
|
$22.22 M
|
$22.76 M
|
$8.69 M
|
$8.43 M
|
$2.04 M
|
$1,000.00
|
$65.21 M
|
| Other Expenses |
$0.00
|
$19.46 M
|
-$919,000.00
|
-$606,000.00
|
-$953,000.00
|
$2.33 M
|
$4.53 M
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$127.62 M
|
$152.04 M
|
$97.54 M
|
$71.16 M
|
$57.09 M
|
$32.38 M
|
$23.15 M
|
$18.88 M
|
$1,000.00
|
$70.43 M
|
| Cost And Expenses |
$0.00
|
$152.04 M
|
$97.54 M
|
$71.16 M
|
$57.09 M
|
$32.38 M
|
$23.15 M
|
$18.88 M
|
$1,000.00
|
$465.91 M
|
| Interest Income |
$10.71 M
|
$9.95 M
|
$3.76 M
|
$91,000.00
|
$785,000.00
|
$938,000.00
|
$543,000.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
-$4,000.00
|
$0.00
|
$80,000.00
|
$176,000.00
|
$134,000.00
|
$0.00
|
$0.00
|
$7.00 M
|
$3.95 M
|
$2.10 M
|
| Depreciation & Amortization |
$0.00
|
$6.10 M
|
$5.01 M
|
$4.07 M
|
$1.95 M
|
$1.24 M
|
$80,000.00
|
$5,000.00
|
$11.85 M
|
$8.09 M
|
| EBITDA |
-$127.62 M |
-$136.54 M |
-$64.70 M |
-$60.41 M |
-$37.41 M |
-$26.88 M |
-$13.74 M |
-$33.77 M |
-$1,000.00 |
$54.87 M |
| EBITDA Ratio |
0
|
0
|
-2.79
|
-6.37
|
-2.2
|
-27.02
|
-1.06
|
-0.03
|
-0
|
0.11
|
| Operating Income Ratio |
0
|
0
|
-2.9
|
-6.31
|
-2.19
|
-31.55
|
-1.83
|
-0.03
|
-0
|
0.09
|
| Total Other Income/Expenses Net |
$10.49 M
|
$9.38 M
|
$2.76 M
|
-$691,000.00
|
-$302,000.00
|
$3.27 M
|
$5.08 M
|
-$14.90 M
|
$0.00
|
$402,000.00
|
| Income Before Tax |
-$117.12 M
|
-$142.66 M
|
-$69.79 M
|
-$62.12 M
|
-$39.49 M
|
-$28.12 M
|
-$9.89 M
|
-$33.78 M
|
-$1,000.00
|
$44.67 M
|
| Income Before Tax Ratio |
0
|
0
|
-2.79
|
-6.38
|
-2.21
|
-28.26
|
-1.21
|
-0.06
|
-0
|
0.09
|
| Income Tax Expense |
$0.00
|
$0.00
|
-$2.76 M
|
-$125,000.00
|
-$2.82 M
|
$19,000.00
|
-$589,000.00
|
$19.09 M
|
$20.38 M
|
$15.67 M
|
| Net Income |
-$117.12 M
|
-$142.66 M
|
-$67.03 M
|
-$62.00 M
|
-$36.68 M
|
-$28.14 M
|
-$9.30 M
|
-$33.78 M
|
-$1,000.00
|
$29.00 M
|
| Net Income Ratio |
0
|
0
|
-2.68
|
-6.37
|
-2.05
|
-28.28
|
-1.14
|
-0.06
|
-0
|
0.06
|
| EPS |
-1.33 |
-3.31 |
-1.63 |
-2 |
-5.01 |
-1.52 |
-0.31 |
-1.26 |
0 |
1.18 |
| EPS Diluted |
-1.33 |
-3.31 |
-1.63 |
-2 |
-5.01 |
-1.52 |
-0.31 |
-1.25 |
0 |
1.16 |
| Weighted Average Shares Out |
$87.87 M
|
$43.04 M
|
$41.08 M
|
$30.95 M
|
$7.32 M
|
$18.56 M
|
$29.80 M
|
$26.77 M
|
$28.05 M
|
$24.50 M
|
| Weighted Average Shares Out Diluted |
$87.87 M
|
$43.04 M
|
$41.08 M
|
$30.95 M
|
$7.32 M
|
$18.56 M
|
$29.80 M
|
$26.97 M
|
$28.05 M
|
$24.99 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
